Sun, Sep 13, 2026 | Updated 05:08 IST
Optimus receives tentative approval from U.S. FDA for Brexpiprazole Tablets
Oct 09, 2021
Hyderabad (Telangana) [India], October 9 (ANI/PNN): Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and...
CDSCO suspends manufacturing of eye drops linked to 55 adverse events in United States
Feb 04, 2023
The FDA has restricted the imports of products manufactured by Chennai-based Global Pharma Private Healthcare Limited.
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Aug 19, 2026
Mumbai (Maharashtra) [India], August 19: Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635) ("PPL) has completed the acquisition of an incremental 40.67% stake in Yapan...
Optimus Pharma launched a new Anti-Parkinson's Drug in India
Apr 26, 2021
Hyderabad (Telangana) [India], April 26 (ANI/PNN): Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is...
Provet Pharma Private Limited Raises Fund from N+1 Capital
Mar 21, 2022
Chennai (Tamil Nadu) [India], March 21 (ANI/NewsVoir): Provet Pharma Private Limited, headquartered in Chennai, one of the fast-growing animal health care companies in India,...
Optimus announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir conducted in India
Jul 21, 2021
Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules...
Drugs manufacturer from Hyderabad on overdrive
May 19, 2021
Orange Biotech Private Limited Offers High-Return PCD Pharma Franchise Opportunities Across India
Dec 25, 2025
Optimus Pharma granted permission for restricted use under emergency situation from the DCGI for its COVID-19 pill MOLNUPIRAVIR
Dec 28, 2021
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild to moderate COVID-19
May 25, 2021
Cyril Amarchand Mangaldas advises the book running lead managers in relation to the IPO of Mankind Pharma Limited
Jun 01, 2023
Piramal Pharma Consumer Products Division launches Wellify.in, an in-house D2C platform for health and wellness products
Nov 07, 2022
Related Videos
No Result Found